# NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
> **ANDA219692** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT · Approved 2025-08-11
## Drug
- **FDA Application Number:** ANDA219692
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
- **Generic name:** Norepinephrine Bitartrate
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SAGENT
- **First approval:** 2025-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219692)
---
*AI Analytics · CC0 1.0*